Literature DB >> 8209423

Open reading frames in a 4556 nucleotide sequence within MDV-1 BamHI-D DNA fragment: evidence for splicing of mRNA from a new viral glycoprotein gene.

Y Becker1, Y Asher, E Tabor, I Davidson, M Malkinson.   

Abstract

A DNA segment of the MDV-1 BamHI-D fragment was sequenced, and the open reading frames (ORFs) present in the 4556 nucleotide fragment were analyzed by computer programs. Computer analysis identified 19 putative ORFs in the sequence ranging from a coding capacity of 37 amino acids (aa) (ORF-1a) to 684aa (ORF-1). The special properties of four ORFs (1a, 1, 2, and 3) were investigated. Two adjacent ORFs, ORF-1a and ORF-1, were found by computer analysis to have the properties of two introns encoding a glycoprotein: ORF-1a encodes an aa sequence with the properties of a signal peptide, and ORF-1 encodes a polypeptide with a membrane anchor domain and putative N-glycosylation sites in the aa sequence. ORF-1a and ORF-1 were found to be transcribed in MDV-1-infected cells. Two RNA transcripts were detected: a precursor RNA and its spliced form. Both are transcribed from a promoter located 5' to ORF-1a, and splice donor and acceptor sites are used to splice the mRNA after cleavage of a 71-nucleotide sequence. This finding suggest that ORF-1a and ORF-1 are two introns of a new MDV-1 glycoprotein gene. The DNA sequence containing ORF-1 was transiently expressed in COS-1 cells, and the viral protein produced in these cells was found to react with anti-MDV serotype-1 Antigen B-specific monoclonal antibodies. These studies indicate that the protein encoded by ORF-1 has antigenic properties resembling Antigen B of MDV-1. A gene homologous to ORF-1 was detected in the genome of both MDV-2(SB1) and MDV-3(HVT), which serve as commercial vaccine strains. Two additional ORFs were noted in the 4556 nucleotide sequence: ORF-2, which encodes a 333 aa polypeptide initiating in the UL and terminating in the TRL prior to the putative origin of replication, and ORF-3, which encodes a 155 aa polypeptide that is partly homologous to the phosphoprotein pp38 encoded by the BamHI-H sequence. The 65 N-terminal aa of the two gene products are identical, both being derived from the nucleotide sequences in the TRL and IRL, respectively. Additional homologous aa sequences are the hydrophobic aa domain in the middle of both proteins. The functions of ORF-2, ORF-3, and additional ORFs are under study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8209423     DOI: 10.1007/bf01703602

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  34 in total

1.  Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus.

Authors:  K Hirai; K Nakajima; K Ikuta; R Kirisawa; Y Kawakami; T Mikami; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA.

Authors:  K Fukuchi; A Tanaka; L W Schierman; R L Witter; M Nonoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

3.  Transfection of chicken embryo fibroblasts with Marek's disease virus DNA.

Authors:  R W Morgan; J L Cantello; C H McDermott
Journal:  Avian Dis       Date:  1990 Apr-Jun       Impact factor: 1.577

4.  Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus.

Authors:  L J Ross; M Sanderson; S D Scott; M M Binns; T Doel; B Milne
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

5.  Comparison of the sequence of the secretory glycoprotein A (gA) gene in Md5 and BC-1 strains of Marek's disease virus type 1.

Authors:  T Ihara; A Kato; S Ueda; A Ishihama; K Hirai
Journal:  Virus Genes       Date:  1989-11       Impact factor: 2.332

6.  Antigen B of the vaccine strains of Marek's disease virus and herpesvirus of turkeys presents heat-labile group and serotype specific epitopes.

Authors:  M Malkinson; I Davidson; Y Becker
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Alterations in DNA sequence and RNA transcription of the Bam HI-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus.

Authors:  N Ross; M M Binns; M Sanderson; K A Schat
Journal:  Virus Genes       Date:  1993-02       Impact factor: 2.332

9.  Size and composition of Marek's disease virus deoxyribonucleic acid.

Authors:  L F Lee; E D Kieff; S L Bachenheimer; B Roizman; P G Spear; B R Burmester; K Nazerian
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

10.  Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus.

Authors:  N Yanagida; R Ogawa; Y Li; L F Lee; K Nazerian
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  6 in total

1.  The genome of turkey herpesvirus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors:  M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes.

Authors:  M S Parcells; A S Anderson; T W Morgan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  The Transcriptional Landscape of Marek's Disease Virus in Primary Chicken B Cells Reveals Novel Splice Variants and Genes.

Authors:  Luca D Bertzbach; Florian Pfaff; Viktoria I Pauker; Ahmed M Kheimar; Dirk Höper; Sonja Härtle; Axel Karger; Benedikt B Kaufer
Journal:  Viruses       Date:  2019-03-16       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.